Regeneron Pharmaceuticals, Inc. (VIE:REGN)

Regeneron Pharmaceuticals Revenue

Regeneron Pharmaceuticals had revenue of $3.68B USD in the quarter ending June 30, 2025, with 3.62% growth. This brings the company's revenue in the last twelve months to $14.21B, up 5.38% year-over-year. In the year 2024, Regeneron Pharmaceuticals had annual revenue of $14.20B with 8.27% growth.

• Revenue (ttm): $14.21B
• Revenue Growth: +5.38%
• P/S Ratio: 4.25
• Revenue / Employee: $940.96K
• Employees: 15,106
• Market Cap: 51.42B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.20B	1.08B	8.27%
Dec 31, 2023	13.12B	944.30M	7.76%
Dec 31, 2022	12.17B	-3.90B	-24.26%
Dec 31, 2021	16.07B	7.57B	89.14%
Dec 31, 2020	8.50B	1.94B	29.58%